Skip to main content

Advertisement

Log in

A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Introduction

Head and neck squamous cell carcinoma (HNSCC) is one of the most invasive cancer types globally, and distant metastasis (DM) is associated with a poor prognosis. The objective of this study was designed to construct a novel nomogram and risk classification system to predict overall survival (OS) in HNSCC patients presenting with DM at initial diagnosis.

Methods

HNSCC patients with initially diagnosed DM between 2010 and 2015 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Firstly, all patients were randomly assigned to a training cohort and validation cohort (8:2), respectively. The Cox proportional hazards regression model was used to analyze the prognostic factors associated with OS. Then, the nomogram based on the prognostic factors and the predictive ability of the nomogram were assessed by the calibration curves, receiver operating characteristic (ROC) curves and decision curve analysis (DCA). Finally, a risk classification system was established according to the nomogram scores.

Results

A total of 1240 patients initially diagnosed with HNSCC with DM were included, and the 6-, 12- and 18-month OS of HNSCC with DM were 62.7%, 40.8% and 30%, respectively. The independent prognostic factors for HNSCC patients with DM included age, marital status, primary site, T stage, N stage, bone metastasis, brain metastasis, liver metastasis, lung metastasis, surgery, radiotherapy and chemotherapy. Based on the independent prognostic factors, a nomogram was constructed to predict OS in HNSCC patients with DM. The C-index values of the nomogram were 0.713 in the training cohort and 0.674 in the validation cohort, respectively. The calibration curves and DCA also indicated the good predictability of the nomogram. Finally, a risk classification system was built and it revealed a statistically significant difference among the three groups of patients according to the nomogram scores.

Conclusions

Factors associated with the overall survival of HNSCC patients with DM were found. According to the identified factors, we generated a nomogram and risk classification system to predict the OS of patients with initially diagnosed HNSCC with DM. The prognostic nomogram and risk classification system can help to assess survival time and provide guidance when making treatment decisions for HNSCC patients with DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Availability of data and materials

The dataset from SEER database generated and/or analyzed during the current study are available in the SEER dataset repository (https://seer.cancer.gov/).

Abbreviations

HNSCC:

Head and neck squamous cell carcinoma

DM:

Distant metastasis

OS:

Overall survival

SEER:

Surveillance epidemiology and end results

AJCC:

American Joint Committee on Cancer

ROC:

Receiver operating characteristic

AUC:

Area under the curve

DCA:

Decision curve analysis

HR:

Ratio

CI:

Confidence interval

References

  1. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209–249. https://doi.org/10.3322/caac.21660

    Article  Google Scholar 

  2. Tahara M, Muro K, Hasegawa Y et al (2018) Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: analyses from KEYNOTE-012. Cancer Sci 109:771–776. https://doi.org/10.1111/cas.13480

    Article  CAS  Google Scholar 

  3. Guigay J, Auperin A, Fayette J et al (2021) Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014–01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol 22:463–475. https://doi.org/10.1016/S1470-2045(20)30755-5

    Article  CAS  Google Scholar 

  4. Guigay J, Fayette J, Dillies AF et al (2015) Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study. Ann Oncol 26:1941–1947. https://doi.org/10.1093/annonc/mdv268

    Article  CAS  Google Scholar 

  5. Duprez F, Berwouts D, De Neve W et al (2017) Distant metastases in head and neck cancer. Head Neck 39:1733–1743. https://doi.org/10.1002/hed.24687

    Article  Google Scholar 

  6. Adkins DR, Lin JC, Sacco A et al (2021) Palbociclib and cetuximab compared with placebo and cetuximab in platinum-resistant, cetuximab-naive, human papillomavirus-unrelated recurrent or metastatic head and neck squamous cell carcinoma: A double-blind, randomized, phase 2 trial. Oral Oncol 115:105192. https://doi.org/10.1016/j.oraloncology.2021.105192

    Article  CAS  Google Scholar 

  7. Liu JC, Bhayani M, Kuchta K et al (2019) Patterns of distant metastasis in head and neck cancer at presentation: Implications for initial evaluation. Oral Oncol 88:131–136. https://doi.org/10.1016/j.oraloncology.2018.11.023

    Article  Google Scholar 

  8. Kuperman DI, Auethavekiat V, Adkins DR et al (2011) Squamous cell cancer of the head and neck with distant metastasis at presentation. Head Neck 33:714–718. https://doi.org/10.1002/hed.21529

    Article  Google Scholar 

  9. Lim JY, Lim YC, Kim SH et al (2010) Predictive factors of isolated distant metastasis after primary definitive surgery without systemic treatment for head and neck squamous cell carcinoma. Oral Oncol 46:504–508. https://doi.org/10.1016/j.oraloncology.2010.02.005

    Article  Google Scholar 

  10. Coca-Pelaz A, Rodrigo JP, Suarez C (2012) Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Head Neck 34:771–775. https://doi.org/10.1002/hed.21804

    Article  Google Scholar 

  11. Li X, Di B, Shang Y et al (2009) Clinicopathologic risk factors for distant metastases from head and neck squamous cell carcinomas. Eur J Surg Oncol 35:1348–1353. https://doi.org/10.1016/j.ejso.2009.06.010

    Article  CAS  Google Scholar 

  12. Nishijima W, Takooda S, Tokita N et al (1993) Analyses of distant metastases in squamous cell carcinoma of the head and neck and lesions above the clavicle at autopsy. Arch Otolaryngol Head Neck Surg 119:65–68. https://doi.org/10.1001/archotol.1993.01880130067009

    Article  CAS  Google Scholar 

  13. Zbaren P, Lehmann W (1987) Frequency and sites of distant metastases in head and neck squamous cell carcinoma. An analysis of 101 cases at autopsy. Arch Otolaryngol Head Neck Surg 113:762–764. https://doi.org/10.1001/archotol.1987.01860070076020

    Article  CAS  Google Scholar 

  14. Tang X, Pang T, Yan WF et al (2020) A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. BMC Cancer 20:1095. https://doi.org/10.1186/s12885-020-07599-2

    Article  CAS  Google Scholar 

  15. Hoch S, Katabi N, Daniel H et al (2016) Prognostic value of level IV metastases from head and neck squamous cell carcinoma. Head Neck 38:140–146. https://doi.org/10.1002/hed.23861

    Article  Google Scholar 

  16. Balachandran VP, Gonen M, Smith JJ et al (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173-180. https://doi.org/10.1016/S1470-2045(14)71116-7

    Article  Google Scholar 

  17. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590

    Article  Google Scholar 

  18. Xiao C, Miller AH, Peng G et al (2021) Association of epigenetic age acceleration with risk factors, survival, and quality of life in patients with head and neck cancer. Int J Radiat Oncol Biol Phys 111:157–167. https://doi.org/10.1016/j.ijrobp.2021.04.002

    Article  Google Scholar 

  19. Simpson MC, Challapalli SD, Cass LM et al (2019) Impact of gender on the association between marital status and head and neck cancer outcomes. Oral Oncol 89:48–55. https://doi.org/10.1016/j.oraloncology.2018.12.009

    Article  Google Scholar 

  20. Inverso G, Mahal BA, Aizer AA et al (2015) Marital status and head and neck cancer outcomes. Cancer 121:1273–1278. https://doi.org/10.1002/cncr.29171

    Article  Google Scholar 

  21. Schaefer EW, Wilson MZ, Goldenberg D et al (2015) Effect of marriage on outcomes for elderly patients with head and neck cancer. Head Neck 37:735–742. https://doi.org/10.1002/hed.23657

    Article  Google Scholar 

  22. Takes RP, Rinaldo A, Silver CE et al (2012) Distant metastases from head and neck squamous cell carcinoma. Part I Basic aspects. Oral Oncol 48:775–779. https://doi.org/10.1016/j.oraloncology.2012.03.013

    Article  Google Scholar 

  23. Du E, Mazul AL, Farquhar D et al (2019) Long-term survival in head and neck cancer: impact of site, stage, smoking, and human papillomavirus status. Laryngoscope 129:2506–2513. https://doi.org/10.1002/lary.27807

    Article  Google Scholar 

  24. Shen W, Sakamoto N, Yang L (2015) Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol 22:264–271. https://doi.org/10.1245/s10434-014-3951-8

    Article  Google Scholar 

  25. van der Kamp MF, Muntinghe FOW, Iepsma RS et al (2021) Predictors for distant metastasis in head and neck cancer, with emphasis on age. Eur Arch Otorhinolaryngol 278:181–190. https://doi.org/10.1007/s00405-020-06118-0

    Article  Google Scholar 

  26. Bollig CA, Newberry CI, Galloway TLI et al (2021) Prognostic impact of metastatic site and pattern in patients with metastatic head and neck cancer. Laryngoscope 131:E1838–E1846. https://doi.org/10.1002/lary.29208

    Article  CAS  Google Scholar 

  27. Patel TD, Marchiano E, Chin OY et al (2016) Utility of surgery/radiotherapy in distant metastatic head and neck squamous cell carcinoma: a population-based approach. Otolaryngol Head Neck Surg 154:868–874. https://doi.org/10.1177/0194599815627637

    Article  Google Scholar 

  28. Chow LQM (2020) Head and neck cancer. N Engl J Med 382:60–72. https://doi.org/10.1056/NEJMra1715715

    Article  CAS  Google Scholar 

  29. Vermorken JB, Mesia R, Rivera F et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1127. https://doi.org/10.1056/NEJMoa0802656

    Article  CAS  Google Scholar 

  30. Kabarriti R, Baliga S, Ohri N et al (2019) Radiation therapy for patients with newly diagnosed metastatic head and neck squamous cell carcinoma. Head Neck 41:130–138. https://doi.org/10.1002/hed.25476

    Article  Google Scholar 

  31. Li W, Xiao Y, Xu X et al (2021) A novel nomogram and risk classification system predicting the cancer-specific mortality of patients with initially diagnosed metastatic cutaneous melanoma. Ann Surg Oncol 28:3490–3500. https://doi.org/10.1245/s10434-020-09341-5

    Article  Google Scholar 

  32. Tang X, Zhou X, Li Y et al (2019) A novel nomogram and risk classification system predicting the cancer-specific survival of patients with initially diagnosed metastatic esophageal cancer: a SEER-based study. Ann Surg Oncol 26:321–328. https://doi.org/10.1245/s10434-018-6929-0

    Article  Google Scholar 

  33. Lan LF, Gao CK, Ma CW (2021) Prediction of minor salivary gland carcinoma: a novel nomogram and risk classification system for overall survival and cancer-specific survival. Otolaryngol Head Neck Surg 164:359–368. https://doi.org/10.1177/0194599820938323

    Article  Google Scholar 

  34. Chi C, Fan Z, Yang B et al (2021) The clinical characteristics and prognostic nomogram for head and neck cancer patients with bone metastasis. J Oncol 2021:5859757. https://doi.org/10.1155/2021/5859757

    Article  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

Study design: R-QZ, Y-MZ, and H-YZ. Data collection: W-YS and X-YL. Manuscript preparation: R-QZ, Y-MZ. Data analysis and interpretation: R-QZ and W-YS. H-YZ participated in the design of the study and drafted the manuscript. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Hui-Yong Zhu.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethics approval and informed consent

Not applicable.

Consent for publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhu, RQ., Zhang, YM., Luo, XY. et al. A novel nomogram and risk classification system for predicting overall survival in head and neck squamous cell cancer with distant metastasis at initial diagnosis. Eur Arch Otorhinolaryngol 280, 1467–1478 (2023). https://doi.org/10.1007/s00405-022-07716-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-022-07716-w

Keywords

Navigation